The assessment of “Global Prescription Pharmaceuticals Market” report which is estimated to achieve the market return at 918.74 Billion USD with CAGR of 4.80% during the upcoming forecast period and Prescription Pharmaceuticals market evaluation for the year 2018 XX USD and predicated to appraise tremendously to XX USD by 2023.

The objective of Global Prescription Pharmaceuticals Market report is to enlighten the users with up-to-date market stats, market trends, Prescription Pharmaceuticals market outlook during the forecast period from 2018-2023. The Prescription Pharmaceuticals market size, market overview, business tactics of the leading players and the analysis of market-based on the past, present and future dominating trends will bring the market growth, market strategies, and Prescription Pharmaceuticals development status during the forecast period. The precise Prescription Pharmaceuticals market study in chunks based on key market segments, dominant geographic regions, exclusive market players and Prescription Pharmaceuticals business opportunities will help in making vital business conclusions.

Influence of the global Prescription Pharmaceuticals market report:

* Prescription Pharmaceuticals market analyzes extensive interpretation of all opportunities and objections.

* Competitive developments, strategic alliances, mergers & acquisitions and Prescription Pharmaceuticals research & developments.

* Prescription Pharmaceuticals market latest tech innovations and key events.

* Detailed analysis of business strategies of the Prescription Pharmaceuticals market top key players.

* Growth map decisive analysis of Prescription Pharmaceuticals market in forthcoming years.

* Deeper insights of Prescription Pharmaceuticals industry-specific drivers, restraints and key micro markets.

* Beneficial instincts inside crucial technological and market trends impacting the Prescription Pharmaceuticals market.

The compelling points of the Prescription Pharmaceuticals report are the complete study of key leading market performers, their competitive scenario, segment-wise analysis of Prescription Pharmaceuticals market, a study of market competitors, their consumer base, demand and supply chain scenario and competitive factors. The Prescription Pharmaceuticals product application, manufacturing cost, labour cost, raw materials, key developments and Prescription Pharmaceuticals innovative strategies are listed in this report.

Global Prescription Pharmaceuticals Market leading players & major geographical regions include:

The global Prescription Pharmaceuticals market is segmented on the basis leading players in Prescription Pharmaceuticals market includes 

Gilead Sciences Inc
AstraZeneca plc
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co and A.G.
Pfizer Inc
F. Hoffmann-La Roche

Prescription Pharmaceuticals industry in North America includes US, Canada, Mexico

Prescription Pharmaceuticals industry in Europe includes Germany, UK, France

Prescription Pharmaceuticals industry in Middle East & Africa includes Saudi Arabia, South Africa, Egypt

Prescription Pharmaceuticals industry in Asia-Pacific includes China, Japan, India, Singapore

According to the applications, Prescription Pharmaceuticals market divided into:

Capsules
Tablets
Inhalants and Liquids
Parenterals
Topicals

Based on the types, the Prescription Pharmaceuticals market is categorized into:

Cardiovascular Disorders
Oncology
Inflammatory Conditions
Infectious Diseases
Metabolic Disorders
Respiratory Disorders

Target Audience:

* Major key vendors in the Prescription Pharmaceuticals market

* Global Prescription Pharmaceuticals Industry suppliers and distributors

* Research Organizations and Consulting Firms

* Prescription Pharmaceuticals Research and Development (R&D) Companies and Academic Centers

In short, the global Prescription Pharmaceuticals market offers the fundamental market synopsis, along with the Prescription Pharmaceuticals sales revenue, market profits, market share of Prescription Pharmaceuticals players, SWOT analysis based on manufacturing regions, analysis of modern market trends and conclusions. The Prescription Pharmaceuticals report will serve as a complete guide for emerging and existing market players and aspirants for gaining a competitive business advantage.
https://market.biz/report/global-prescription-pharmaceuticals-market-smr/119021/#inquiry
1.MARKET OVERVIEW

1.1.Definitions

1.2.Research Methodology

1.2.1.Primary Data

1.2.2.Secondary Data

1.2.3.Machine Learning

1.2.4.Research Scope

1.2.5.Years Considered

1.2.6.Currency & Pricing

1.3.Market Segmentation
1.MARKET OVERVIEW

1.1.Definitions

1.2.Research Methodology

1.2.1.Primary Data

1.2.2.Secondary Data

1.2.3.Machine Learning

1.2.4.Research Scope

1.2.5.Years Considered

1.2.6.Currency & Pricing

1.3.Market Segmentation

2.EXECUTIVE SUMMARY

2.1.Global Prescription Pharmaceuticals Market

2.2.Global Prescription Pharmaceuticals Market Size (US$ Billion), By Therapeutic Segments (2015 vs. 2020)

2.3.Global Prescription Pharmaceuticals Market Size (US$ Billion), By Formulations (2015 vs. 2020)

2.4.Global Prescription Pharmaceuticals Market Size (US$ Billion), By Regions (2015 vs. 2020)

3.MARKET DYNAMICS

3.1.Drivers

3.1.1.Increase in the Ageing Population and Lengthening Life Expectancies

3.1.2.Rising Affluence in Emerging Markets

3.1.3.Widespread Prevalence of Chronic Diseases

3.2.Restraints

3.2.1.Government Policies Aimed at Lowering Prescription Drug Prices

3.2.2.Generics and Biosimilars Drugs Hampering Prescription Pharmaceuticals Growth

3.3.Opportunities

3.3.1.Emerging Marketsare key Pockets

3.3.2.Increased Healthcare Awareness

3.4.Trends

3.4.1.Increased Spending on Specialty Medicines  Hepatitis, Autoimmune Diseases, and Oncology

4.INDUSTRY ANALYSIS

4.1.Supply Chain Analysis

4.2.Regulatory Analysis

4.3.Macroeconomic Indicators

4.3.1.Healthcare Spending (US$ Billion), by Regions (2005 to 2014)

4.3.2.Per Capita Healthcare Spending (US$), by Regions (2005 to 2014)

4.3.3.Public Healthcare Spending (US$ Billion), by Regions (2005 to 2014)

4.4.Ecosystem Analysis

4.4.1.Market Size of Top-25 Prescription Pharmaceuticals (2013 to 2015)

4.4.2.Therapeutic Segments Benchmarking

5.PRESCRIPTION PHARMACEUTICALS MARKET, BY THERAPEUTIC SEGMENTS

5.1.Introduction

5.1.1.Global Prescription Pharmaceuticals Market Size& Forecast (US$ Billion), By Therapeutic Segments (2015)

5.1.2.Global Prescription Pharmaceuticals Market Size& Forecast (US$ Billion), By Therapeutic Segments (2013  2020)

5.2.Cardiovascular Disorders

5.2.1.Global Prescription Pharmaceuticals Market Size& Forecast (US$ Billion), By Cardiovascular Disorders, (2013  2020)

5.2.2.Global Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

5.2.3.Global Prescription Pharmaceuticals for Cardiovascular Disorders Market Size& Forecast (US$ Billion), By Regions (2013  2020)

5.2.4.North America Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ Billion), By Country (2013  2020)

5.2.5.Europe Prescription Pharmaceuticals for Cardiovascular Disorders Market Size& Forecast (US$ Billion), By Country (2013  2020)

5.2.6.Asia Prescription Pharmaceuticals for Cardiovascular Disorders Market Size (US$ Billion)& Forecast (US$ Billion), By Country (2013  2020)

5.2.7.Rest of the World (RoW) Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ Billion), By Country (2013  2020)

5.3.Oncology

5.3.1.Global Prescription Pharmaceuticals Market Size& Forecast (US$ Billion), By Oncology (2013  2020)

5.3.2.Global Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

5.3.3.Global Prescription Pharmaceuticals for Oncology Market Size& Forecast (US$ Billion), By Regions (2013  2020)

5.3.4.North America Prescription Pharmaceuticals for Oncology Market Size& Forecast (US$ Billion), By Country (2013  2020)

5.3.5.Europe Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion), By Country (2013  2020)

5.3.6.Asia Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion), By Country (2013  2020)

5.3.7.Rest of the World (RoW) Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion), By Country (2013  2020)

5.4.Inflammatory Conditions

5.4.1.Global Prescription Pharmaceuticals Market Size& Forecast (US$ Billion),By Inflammatory Conditions (2013  2020)

5.4.2.Global Prescription Pharmaceuticals Market Size& Forecast for Inflammatory Conditions (US$ Billion), By Regions (2015 vs. 2020)

5.4.3.Global Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Regions (2013  2020)

5.4.4.North America Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Country (2013  2020)

5.4.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Country (2013  2020)

5.4.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Country (2013  2020)

5.4.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Country (2013  2020)

5.5.Infectious Diseases

5.5.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Infectious Diseases (2013  2020)

5.5.2.Global Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Regions (2015 vs. 2020)

5.5.3.Global Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Regions (2013  2020)

5.5.4.North America Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Country (2013  2020)

5.5.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Country (2013  2020)

5.5.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Country (2013  2020)

5.5.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Country (2013  2020)

5.6.Metabolic Disorders

5.6.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Metabolic Disorders (2013  2020)

5.6.2.Global Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Regions (2015 vs. 2020)

5.6.3.Global Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Regions (2013  2020)

5.6.4.North America Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Country (2013  2020)

5.6.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Country (2013  2020)

5.6.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Country (2013  2020)

5.6.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Country (2013  2020)

5.7.Respiratory Disorders

5.7.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Respiratory Disorders (2013  2020)

5.7.2.Global Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Regions (2015 vs. 2020)

5.7.3.Global Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Regions (2013  2020)

5.7.4.North America Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Country (2013  2020)

5.7.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Country (2013  2020)

5.7.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Country (2013  2020)

5.7.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Country (2013  2020)

5.8.Other Therapeutic Segments

5.8.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Other Therapeutic Segments (2013  2020)

5.8.2.Global Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Regions (2015 vs. 2020)

5.8.3.Global Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Regions (2013  2020)

5.8.4.North America Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Country (2013  2020)

5.8.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Country (2013  2020)

5.8.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Country (2013  2020)

5.8.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Country (2013  2020)

6.PRESCRIPTION PHARMACEUTICALS MARKET, BY FORMULATIONS

6.1.Introduction

6.1.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2015)

6.1.2.Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

6.2.Capsules

6.2.1.Global Capsules Market Size & Forecast (US$ Billion) (2013  2020)

6.2.2.Global Capsules Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

6.2.3.Global Capsules Market Size & Forecast (US$ Billion), By Regions (2013  2020)

6.3.Tablets

6.3.1.Global Tablets Market Size & Forecast (US$ Billion), (2013  2020)

6.3.2.Global Tablets Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

6.3.3.Global Tablets Market Size & Forecast (US$ Billion), By Regions (2013  2020)

6.4.Inhalants and Liquids

6.4.1.Global Inhalants and Liquids Market Size & Forecast (US$ Billion), (2013  2020)

6.4.2.Global Inhalants and Liquids Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

6.4.3.Global Inhalants and Liquids Market Size & Forecast (US$ Billion), By Regions (2013  2020)

6.5.Parenterals

6.5.1.Global Parenteral Market Size Market Size & Forecast (US$ Billion), (2013  2020)

6.5.2.Global Parenteral Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

6.5.3.Global Parenterals Market Size & Forecast (US$ Billion), By Regions (2013  2020)

6.6.Topicals

6.6.1.Global TopicalsMarket Size & Forecast (US$ Billion), (2013  2020)

6.6.2.Global Topicals Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

6.6.3.Global Topicals Market Size & Forecast (US$ Billion), By Regions (2013  2020)

7.PRESCRIPTION PHARMACEUTICALS MARKET, BY REGIONS

7.1.Introduction

7.1.1.Global Prescription Pharmaceuticals Market Size vs. CAGR% (2015  2020), By Regions

7.1.2.Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Regions (2013  2020)

7.2.North America

7.2.1.North America Prescription Pharmaceuticals Market Size & Forecast (US$ Billion),By Country (2013  2020)

7.2.2.North America Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), (2013  2020)

7.2.3.North America Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Therapeutic Segments (2013  2020)

7.2.4.North America Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

7.3.Europe

7.3.1.Europe Prescription Pharmaceuticals Market Size & Forecast (US$ Billion),By Country (2013  2020)

7.3.2.Europe Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), (2013  2020)

7.3.3.Europe Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Therapeutic Segments (2013  2020)

7.3.4.Europe Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

7.4.Asia

7.4.1.Asia Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Country (2013  2020)

7.5.Asia Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), (2013  2020)

7.5.1.Asia Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Therapeutic Segments (2013  2020)

7.5.2.Asia Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

7.6.Rest of the World (RoW)

7.6.1.RoW Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Country, (2013  2020)

7.6.2.Row Prescription Pharmaceuticals Market Size & Forecast (US$ Billion),  (2013  2020)

7.6.3.RoW Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Therapeutic Segments (2013  2020)

7.6.4.RoW Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

8.COMPETITIVE LANDSCAPE

8.1.Market Share Analysis

8.2.Market Positioning of Key Players

9.COMPANY PROFILES

9.1.AstraZeneca (U.K.)

9.1.1.Financial Overview: AstraZeneca plc (U.K.) (Europe) (2013 to 2015)

9.1.2.Revenues of Top-3 Pharmaceutical Products AstraZeneca plc (U.K.) (Europe) (2013 to 2015)

9.2.Bayer AG (Germany)

9.2.1.Financial Overview: Bayer AG (Germany)(Europe) (2013 to 2015)

9.2.2.Revenues of Top-3 Pharmaceutical Products:Bayer AG (Germany)(Europe) (2013 to 2015)

9.3.Gilead Sciences

9.3.1.Financial Overview: Gilead Sciences, Inc. (U.S.)(2013 to 2015)

9.3.2.Revenues of Top-3 Pharmaceutical Products:Gilead Sciences, Inc. (U.S.) (2013 to 2015)

9.4.GlaxoSmithKline

9.4.1.Financial Overview: GlaxoSmithKline plc (U.K.) (Europe)(2013 to 2015)

9.4.2.Revenues of Top-3 Pharmaceutical Products:GlaxoSmithKline plc (U.K.) (Europe) (2013 to 2015)

9.5.Johnson & Johnson

9.5.1.Financial Overview: Johnson & Johnson (U.S.) (2013 to 2015)

9.5.2.Revenues of Top-3 Pharmaceutical Products: Johnson & Johnson (U.S.) (2013 to 2015)

9.6.Merck & Co

9.6.1.Financial Overview: Merck & Co., Inc. (U.S.) (2013 to 2015)

9.6.2.Revenues of Top-3 Pharmaceutical Products: Merck & Co., Inc. (U.S.) (2013 to 2015)

9.7.Novartis A.G.

9.7.1.Financial Overview: Novartis AG (Switzerland) (Europe) (2013 to 2015)

9.7.2.Revenues of Top-3 Pharmaceutical Products: Novartis AG (Switzerland) (Europe) (2013 to 2015)

9.8.Pfizer

9.8.1.Financial Overview: Pfizer Inc. (U.S.) (2013 to 2015)

9.8.2.Revenues of Top-3 Pharmaceutical Products: Pfizer Inc. (U.S.) (2013 to 2015)

9.9.F. Hoffmann-La Roche

9.9.1.Financial Overview: F. Hoffmann-La Roche (Switzerland) (Europe) (2013 to 2015)

9.9.2.Revenues of Top-3 Pharmaceutical Products: Hoffmann-La Roche (Switzerland) (Europe) (2013 to 2015)

9.10.Sanofi S.A

9.10.1.Financial Overview: Sanofi S.A. (France) (Europe) (2013 to 2015)

9.10.2.Revenues of Top-3 Pharmaceutical Products: Sanofi S.A. (France) (Europe) (2013 to 2015)

10.SCALAR 360 DEGREE MARKET REVIEW

11.APPENDIX

11.1.Acronyms

11.2.Related Reports

 
LIST OF TABLES

Table 1.     Global Prescription Pharmaceuticals Market

Table 2.     Global Prescription Pharmaceuticals Market Size (US$ Billion), By Therapeutic Segments (2015 vs. 2020)

Table 3.     Global Prescription Pharmaceuticals Market Size (US$ Billion), By Formulations (2015 vs. 2020)

Table 4.     Global Prescription Pharmaceuticals Market Size (US$ Billion), By Regions (2015 vs. 2020)

Table 5.     Healthcare Spending (US$ Billion), by Regions (2005 to 2014)

Table 6.     Per Capita Healthcare Spending (US$), by Regions (2005 to 2014)

Table 7.     Public Healthcare Spending (US$ Billion), by Regions (2005 to 2014)

Table 8.     Market Size of Top-25 Prescription Pharmaceuticals (2013 to 2015)

Table 9.     Therapeutic Segments Benchmarking

Table 10.   Global Prescription Pharmaceuticals Market Size& Forecast (US$ Billion),By Therapeutic Segments (2013  2020)

Table 11.   Global Prescription Pharmaceuticals Market Size& Forecast (US$ Billion), By Cardiovascular Disorders, (2013  2020)

Table 12.   Global Prescription Pharmaceuticals for Cardiovascular Disorders Market Size& Forecast (US$ Billion), By Regions (2013  2020)

Table 13.   North America Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ Billion), By Country (2013  2020)

Table 14.   Europe Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ Billion), By Country (2013  2020)

Table 15.   Asia Prescription Pharmaceuticals for Cardiovascular Disorders Market Size (US$ Billion) for Asia, By Country (2013  2020)

Table 16.   Rest of the World (RoW) Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ Billion), By Country (2013  2020)

Table 17.   Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion),By Oncology (2013  2020)

Table 18.   Global Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion), By Regions (2013  2020)

Table 19.   North America Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion), By Country (2013  2020)

Table 20.   Europe Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion),  By Country (2013  2020)

Table 21.   Asia Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion), By Country (2013  2020)

Table 22.   Rest of the World (RoW), Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion),By Country (2013  2020)

Table 23.   Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Inflammatory Conditions (2013  2020)

Table 24.   Global Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Regions (2013  2020)

Table 25.   North America Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Country (2013  2020)

Table 26.   Europe Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Country (2013  2020)

Table 27.   Asia Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Country (2013  2020)

Table 28.   Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ Billion), By Country (2013  2020)

Table 29.   Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Infectious Diseases (2013  2020)

Table 30.   Global Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion),By Regions (2015 vs. 2020)

Table 31.   Global Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Regions (2013  2020)

Table 32.   North America Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Country (2013  2020)

Table 33.   Europe Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Country (2013  2020)

Table 34.   Asia Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Country (2013  2020)

Table 35.   Rest of the World (RoW)Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ Billion), By Country (2013  2020)

Table 36.   Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Metabolic Disorders (2013  2020)

Table 37.   Global Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Regions (2013  2020)

Table 38.   North America Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Country (2013  2020)

Table 39.   Europe Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Country (2013  2020)

Table 40.   Asia Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Country (2013  2020)

Table 41.   Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion),By Country (2013  2020)

Table 42.   Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Respiratory Disorders (2013  2020)

Table 43.   Global Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Regions (2013  2020)

Table 44.   North America Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Country (2013  2020)

Table 45.   Europe Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Country (2013  2020)

Table 46.   Asia Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Country (2013  2020)

Table 47.   Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Country (2013  2020)

Table 48.   Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Other Therapeutic Segments (2013  2020)

Table 49.   Global Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Regions (2013  2020)

Table 50.   North America Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Country (2013  2020)

Table 51.   Europe Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Country (2013  2020)

Table 52.   Asia Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Country (2013  2020)

Table 53.   Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Country (2013  2020)

Table 54.   Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

Table 55.   Global Capsules Market Size & Forecast (US$ Billion) (2013  2020)

Table 56.   Global Capsules Market Size & Forecast (US$ Billion), By Regions (2013  2020)

Table 57.   Global Tablets Market Size & Forecast (US$ Billion), (2013  2020)

Table 58.   Global Tablets Market Size & Forecast (US$ Billion), By Regions (2013  2020)

Table 59.   Global Inhalants and Liquids Market Size & Forecast (US$ Billion), (2013  2020)

Table 60.   Global Inhalants and Liquids Market Size & Forecast (US$ Billion), By Regions (2013  2020)

Table 61.   Global Parenteral Market Size & Forecast (US$ Billion), (2013  2020)

Table 62.   Global Parenterals Market Size & Forecast (US$ Billion),  By Regions (2013  2020)

Table 63.   Global TopicalsMarket Size & Forecast (US$ Billion), (2013  2020)

Table 64.   Global Topicals Market Size & Forecast (US$ Billion), By Regions (2013  2020)

Table 65.   Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Regions (2013  2020)

Table 66.   North America Prescription Pharmaceuticals Market Size & Forecast (US$ Billion),By Country (2013  2020)

Table 67.   North America Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), (2013  2020)

Table 68.   North America Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Therapeutic Segments (2013  2020)

Table 69.   North America Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

Table 70.   Europe Prescription Pharmaceuticals Market Size & Forecast (US$ Billion),By Country (2013  2020)

Table 71.   Europe Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), (2013  2020)

Table 72.   Europe Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Therapeutic Segments (2013  2020)

Table 73.   Europe Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

Table 74.   Asia Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Country (2013  2020)

Table 75.   Asia Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), (2013  2020)

Table 76.   Asia Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Therapeutic Segments (2013  2020)

Table 77.   Asia Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

Table 78.   RoW Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Country, (2013  2020)

Table 79.   RoW Prescription Pharmaceuticals Market Size & Forecast (US$ Billion),  (2013  2020)

Table 80.   RoW Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Therapeutic Segments (2013  2020)

Table 81.   RoW Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2013  2020)

Table 82.   Financial Overview: AstraZeneca plc (U.K.) (Europe) (2013 to 2015)

Table 83.   Revenues of Top-3 Pharmaceutical Products AstraZeneca plc (U.K.) (Europe) (2013 to 2015)

Table 84.   Financial Overview: Bayer AG (Germany)(Europe) (2013 to 2015)

Table 85.   Revenues of Top-3 Pharmaceutical Products:Bayer AG (Germany)(Europe) (2013 to 2015)

Table 86.   Financial Overview: Gilead Sciences, Inc. (U.S.)(2013 to 2015)

Table 87.   Revenues of Top-3 Pharmaceutical Products:Gilead Sciences, Inc. (U.S.) (2013 to 2015)

Table 88.   Financial Overview: GlaxoSmithKline plc (U.K.) (Europe)(2013 to 2015)

Table 89.   Revenues of Top-3 Pharmaceutical Products:GlaxoSmithKline plc (U.K.) (Europe) (2013 to 2015)

Table 90.   Financial Overview: Johnson & Johnson (U.S.) (2013 to 2015)

Table 91.   Revenues of Top-3 Pharmaceutical Products: Johnson & Johnson (U.S.) (2013 to 2015)

Table 92.   Financial Overview: Merck & Co., Inc. (U.S.) (2013 to 2015)

Table 93.   Revenues of Top-3 Pharmaceutical Products: Merck & Co., Inc. (U.S.) (2013 to 2015)

Table 94.   Financial Overview: Novartis AG (Switzerland) (Europe) (2013 to 2015)

Table 95.   Revenues of Top-3 Pharmaceutical Products: Novartis AG (Switzerland) (Europe) (2013 to 2015)

Table 96.   Financial Overview: Pfizer Inc. (U.S.) (2013 to 2015)

Table 97.   Revenues of Top-3 Pharmaceutical Products: Pfizer Inc. (U.S.) (2013 to 2015)

Table 98.   Financial Overview: F. Hoffmann-La Roche (Switzerland) (Europe) (2013 to 2015)

Table 99.   Revenues of Top-3 Pharmaceutical Products: Hoffmann-La Roche (Switzerland) (Europe) (2013 to 2015)

Table 100. Financial Overview: Sanofi S.A. (France) (Europe) (2013 to 2015)

Table 101. Revenues of Top-3 Pharmaceutical Products: Sanofi S.A. (France) (Europe) (2013 to 2015)

Table 102. Acronyms


List of Figures

Figure 1.    Research Methodology

Figure 2.    Prescription Pharmaceuticals Market,By Therapeutic Segments

Figure 3.    Prescription Pharmaceuticals Market, By Formulations

Figure 4.    Prescription Pharmaceuticals Market, By Regions

Figure 5.    Global Prescription Pharmaceuticals Market Size& Forecast (US$ Billion),By Therapeutic Segments (2015)

Figure 6.    Global Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

Figure 7.    Global Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

Figure 8.    Global Prescription Pharmaceuticals Market Size& Forecast for Inflammatory Conditions (US$ Billion), By Regions (2015 vs. 2020)

Figure 9.    Global Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ Billion), By Regions (2015 vs. 2020)

Figure 10. Global Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ Billion), By Regions (2015 vs. 2020)

Figure 11. Global Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ Billion), By Regions (2015 vs. 2020)

Figure 12. Global Prescription Pharmaceuticals Market Size & Forecast (US$ Billion), By Formulations (2015)

Figure 13. Global Capsules Market Size & Forecast (US$ Billion),  By Regions (2015 vs. 2020)

Figure 14. Global Tablets Market Size & Forecast (US$ Billion),  By Regions (2015 vs. 2020)

Figure 15. Global Inhalants and Liquids Market Size & Forecast (US$ Billion),  By Regions (2015 vs. 2020)

Figure 16. Global Parenteral Market Size & Forecast (US$ Billion),  By Regions (2015 vs. 2020)

Figure 17. Global Topicals Market Size & Forecast (US$ Billion), By Regions (2015 vs. 2020)

Figure 18. Global Prescription Pharmaceuticals Market Size vs. CAGR% (2015  2020), By Regions

Figure 19. Market Share Analysis

Figure 20. Market Positioning of Key Players

Inquiry Form

Thank you for contacting us.

Your form has been submitted successfully. Our representative will contact you shortly.

Warm regards,

James Johnson | Director and Sales Head
Telephone No: +1(857)2390696
Market.biz
E-mail: inquiry@market.biz | Web: www.market.biz

Request For Sample

Thank you for contacting us.

Your form has been submitted successfully. Our representative will contact you shortly.

Warm regards,

James Johnson | Director and Sales Head
Telephone No: +1(857)2390696
Market.biz
E-mail: inquiry@market.biz | Web: www.market.biz

GlobalMarketFacts

Stefen is working in advertising and journalism and has written for publications like Prudour Network, TFN, and GMF. He was an Editor of GMF and is now a consultant for them.